Dr. Cohn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1600 Clifton Rd Ne
Ms C-09
Atlanta, GA 30329Phone+1 404-639-6039- Is this information wrong?
Education & Training
- Children's Hospital/Boston Medical CenterResidency, Pediatrics, 2001 - 2004
- Emory University School of MedicineClass of 2001
Certifications & Licensure
- GA State Medical License 2004 - 2025
- WI State Medical License 2014 - 2019
- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 8 citationsOverview of the United States' Immunization Program.Lauren Roper, Mary Ann Kirkconnell Hall, Amanda C. Cohn> ;The Journal of Infectious Diseases. 2021 Sep 30
- 11 citationsAddressing Vaccine Hesitancy in the Age of COVID-19.Allison Fisher, Sarah Mbaeyi, Amanda C. Cohn> ;Academic Pediatrics. 2021 Mar 19
- 3 citationsRecommended Childhood and Adolescent Immunization Schedule: United States, 2021.Yvonne Maldonado, Sean T. O’Leary, Ritu Banerjee, James D. Campbell, Mary T. Caserta, Jeffrey S. Gerber, Athena P. Kourtis, Ruth Lynfield, Flor M. Munoz, Dawn Nolt, Ad...> ;Pediatrics. 2021 Mar 1
- Join now to see all
Journal Articles
- Review of the Economic Evidence Presented to the United States Advisory Committee on Immunization Practices, 2012–2016☆Amanda Cohn, MD, ScienceDirect
Lectures
- Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United StatesNational Foundation for Infectious Diseases, Miami, Florida - 11/2/2012
- Review Understanding Barriers and Predictors of Maternal Immunization: Identifying Gaps Through an Exploratory Literature ReviewNational Foundation for Infectious Diseases, Chicago, Illinois - 3/8/2013
Authored Content
- Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United StatesJuly 2020
Press Mentions
- FDA Panel Recommends RSV Vaccine to Protect Young InfantsMay 19th, 2023
- FDA Panel Recommends RSV Vaccine to Protect Young BabiesMay 18th, 2023
- FDA Advisors Recommend GSK RSV Vaccine, but Flag Potential Safety RisksMarch 1st, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: